Anemia, a common hematological disorder, is characterized by a decrease in the number of red blood cells or a reduction in hemoglobin concentration. It can be a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive guide to the diagnostic approach to anemia, facilitating its efficient and accurate diagnosis.
The initial evaluation of anemia should involve a detailed patient history and physical examination. The history should focus on symptoms related to blood loss, dietary intake, medications, family history, and associated systemic diseases. Physical examination can provide clues about the underlying cause, such as pallor, jaundice, or splenomegaly.
Complete blood count (CBC) and peripheral smear are the cornerstones of anemia diagnosis. CBC provides information about hemoglobin levels, red blood cell indices, and reticulocyte count. Peripheral smear can reveal morphological abnormalities in red blood cells, aiding in the differential diagnosis. Further investigations like serum iron studies, vitamin B12, and folate levels can help identify the cause of anemia.
When initial investigations are inconclusive, advanced diagnostic tools may be utilized. Bone marrow aspiration or biopsy may be required in cases of suspected marrow pathology. Genetic testing can be useful in diagnosing hereditary hemolytic anemias. Endoscopy or colonoscopy may be needed to identify sources of gastrointestinal bleeding.
Anemia is a complex disorder with a wide array of causes, necessitating a systematic and comprehensive diagnostic approach. A thorough history, physical examination, and appropriate laboratory investigations form the backbone of anemia diagnosis. In certain cases, advanced diagnostic tools may be required. By following a structured approach, healthcare professionals can efficiently diagnose and manage this common yet diverse condition.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation